Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension. The less-than-adequate effect of beta-blockers in lowerin...
Saved in:
| Main Authors: | Hirofumi Tomiyama, Akira Yamashina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2014/919256 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta blockers and their combinations in the management of hypertension
by: J.A. Ker
Published: (2012-10-01) -
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01) -
THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01) -
Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
by: Maryam Izadi, et al.
Published: (2024-10-01) -
The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
by: A. O. Konradi, et al.
Published: (2018-12-01)